arrow
O

Ovidiu Horea Bedreag

Victor Babes University of Medicine and Pharmacy Timisoara
H指数:19
被引数:1,582

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment-Emergent Cefiderocol Resistance in Critically Ill Patients: A Narrative Review of Incidence, Mechanisms, Detection Pitfalls and Implications for Surveillance and Stewardship

治疗中出现的美罗培南耐药性在危重患者中的发生率、机制、检测难点及对监测和抗生素管理的影响:一项叙述性综述

2026-10-300
OA
Aztreonam–Avibactam (Emblaveo®) for Carbapenem-Resistant and Metallo-β-Lactamase-Producing Gram-Negative Infections: A Comprehensive Review

阿兹特罗南–阿维巴坦(Emblaveo®)治疗碳青霉烯耐药和金属β-内酰胺酶产生革兰氏阴性菌感染:一项全面综述

2026-10-230
OA
Cytokine and Vasopressor Trajectories During Continuous Renal Replacement Therapy with oXiris, CytoSorb, or Standard Haemofilters in Sepsis-Associated Acute Kidney Injury: An Exploratory Retrospective Cohort Study

细胞因子和血管加压素在连续肾替代治疗中使用oXiris、CytoSorb或标准血液滤过器治疗脓毒症相关急性肾损伤时的变化轨迹:一项探索性回顾性队列研究

2026-10-030
OA
Real-World Use of Cefiderocol for Multidrug-Resistant Gram-Negative Infections in Critically Ill ICU Patients: A Single-Center Case Series

重症ICU患者中针对多重耐药革兰阴性感染的铁载体头孢菌素在真实世界中的应用:一项单中心病例系列研究

2026-07-260
OA
True Preoperative Liquid Fasting in Romania—A Secondary Analysis of the Thirst Study

罗马尼亚真实术前液体禁食情况——一项“口渴研究”的二次分析

2026-05-280
OAAI
Endothelial Activation Phenotypes and Interleukin-6 Response After Therapeutic Plasma Exchange in Severe COVID-19-Associated Sepsis: A Retrospective Cohort Study

内皮活化表型及白细胞介素-6反应在严重COVID-19相关脓毒症接受治疗性血浆置换后的变化:一项回顾性队列研究

2026-04-050
OAAI
Continuous Training, Protocol Adherence and Safety Culture in Anaesthesia and Intensive Care Units in Romania: A Cross-Sectional Study

罗马尼亚麻醉科和重症监护病房的持续培训、操作规程依从性及安全文化:一项横断面研究

2026-03-010
PRE
Rapid Molecular Diagnostics for MDR Nosocomial Infections in ICUs: Integration with Prevention, Stewardship, and Novel Therapies

ICU中MDR医院感染快速分子诊断:与预防、管理及新型疗法的整合

2025-11-300
OAAI
Budget Impact of Preoperative Anemia Management, the First Pillar of Patient Blood Management, on the Romanian Healthcare System

术前贫血管理的预算影响——患者血液管理的第一支柱——对罗马尼亚医疗保健系统的影响

2025-11-080
OAAI